Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Cyclosporine Ophthalmic Suspension [Restasis]

 
National Institutes of Health

Related topics

Related topics

3 relations

Narrower (1)

Cyclosporine 0.5 MG/ML Ophthalmic Suspension [Restasis]
Ophthalmic SuspensionRestasis

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Clinical efficacy of combined topical 0.05% cyclosporine A and 0.1% sodium hyaluronate in the dry eyes with meibomian gland dysfunction.
AIM To investigate the efficacy of combined topical 0.05% cyclosporine A (CsA; Restasis®, Allergan pharmaceuticals, USA) and 0.1… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2018
2018
[Prospective, monocentric, uncontrolled study of efficacy, tolerance and adherence of cyclosporin 0.1 % for severe dry eye syndrome].
PURPOSE To evaluate the efficacy, tolerability and treatment adherence of Ikervis® (Santen, SAS) (ciclosporine 0.1 %) for first… Expand
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2017
2017
[Influence of Aging on Severity and Anti-Inflammatory Treatment of Experimental Dry Eye Disease].
Purpose Aging is an important factor in dry-eye disease that has not been studied in the context of therapeutic measures. Aging… Expand
Is this relevant?
2017
2017
Einfluss von Alterung auf Schweregrad und antientzündliche Therapie des experimentellen Trockenen Auges
Hintergrund Alterung ist ein wichtiger, bislang in Bezug auf therapeutische Masnahmen jedoch nur unzureichend berucksichtigter… Expand
Is this relevant?
2016
2016
A semifluorinated alkane (F4H5) as novel carrier for cyclosporine A: a promising therapeutic and prophylactic option for topical treatment of dry eye
PurposeCyclosporine A (Cs) has been used as effective topical therapy for inflammatory dry eye disease since more than a decade… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2014
2014
Supercritical fluid-mediated liposomes containing cyclosporin A for the treatment of dry eye syndrome in a rabbit model: comparative study with the conventional cyclosporin A emulsion
Background The objective of this study was to compare the efficacy of cyclosporin (CsA)-encapsulated liposomes with the… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2013
2013
Evaluation of cyclosporine A eye penetration after administration of liposomal or conventional forms in animal model
A lot of researches have investigated the effects of topical cyclosporine A on the eye surface layers’ diseases. By now the main… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
Highly Cited
2011
Highly Cited
2011
Topical loteprednol pretreatment reduces cyclosporine stinging in chronic dry eye disease.
PURPOSE This retrospective, clinical comparative analysis describes differences in clinical signs and symptoms and medication… Expand
Is this relevant?
2011
2011
Ophthalmic delivery of cyclosporine A by punctal plugs.
  • C. Gupta, A. Chauhan
  • Journal of controlled release : official journal…
  • 2011
    • Corpus ID: 36260514
Dry eyes are treated by instillation of eye drops of cyclosporine A emulsion or by punctal plug insertion in canaliculus to block… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2008
2008
Clinical Effect of Cyclosporine 0.05% Eye Drops in Dry Eye Syndrome Patients.
Purpose: We conducted a study to evaluate the change of tear secretion and symptoms in the patients with dry eye syndrome after… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE